LIPELLA PHARMACEUTICALS INC (LIPO)

US53630L1008 - Common Stock

3.17  -0.01 (-0.31%)

After market: 3.29 +0.12 (+3.79%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-6-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
507.20K449.62K184.16K259.35K961.68K
Operating Expenses
4.76M5.20M2.77M2.18M1.02M
Research and Development
2.79M3.04M2.55M1.46M975.96K
Selling, General, and Administrative Expenses
1.97M2.16M226.19K718.38K42.59K
Operating Income
-4.26M-4.75M-2.59M-1.92M-56.87K
Interest Income/Expense
113.75K126.99K-7.93K-6.73K-4.80K
Other Income/Expense
N/A0.00-50.0057.09K0.00
Income Before Taxes
-4.14M-4.62M-2.60M-1.87M-61.66K
Income Tax
N/AN/A0.000.000.00
Net Income
-4.14M-4.62M-2.60M-1.87M-61.66K
EBITDA
-4.25M-4.74MN/AN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-3.34-6.16-5.12-2.60-0.01
 
Statistics
Profit Margin
-816.72%-1027.31%-1410.56%-719.29%-6.41%
Operating Profit Margin
-839.15%-1055.55%-1406.23%-738.70%-5.91%

All data in USD

Charts